Oestrogen receptor β5 and epidermal growth factor receptor synergistically promote lung cancer progression

Oestrogen receptor β5 and epidermal growth factor receptor synergistically promote lung cancer progression

Oestrogen receptor beta (ERβ) and epidermal growth factor receptor (EGFR) pathway can synergistically promote the proliferation, invasion, and metastasis of non-small-cell lung cancer (NSCLC) cells. ERβ has five subtypes, and the selective splicing of exon 8 in ERβ5 transcription translational phase...

Full description

Bibliographic Details
Main Authors: Yuquan Bai, Wulin Shen, Li Zhang, Zetian Yang, Lecai Xiong, Hexiao Tang, Jinping Zhao
Format: Article
Language:English
Published: Taylor & Francis Group 2018-05-01
Series:Autoimmunity
Subjects:
non-small cell lung cancer
erβ5
egfr
gefitinib
erk
Online Access:http://dx.doi.org/10.1080/08916934.2018.1486825

Internet

http://dx.doi.org/10.1080/08916934.2018.1486825

Similar Items